NHS Scotland, AZ and Scottish universities partner for kidney health research
The collaboration aims to develop new medicines to reduce chronic kidney disease in Scotland
Read More
Tag: astrazeneca
Study reveals new insights into ‘gene misbehaviour’ in healthy populations
The findings could support investigations into human genetics and various complex diseases
Read More
Francis Crick, UCL and AZ identify why treatment fails for NSCLC patients
NSCLC accounts for around 85% of all lung cancer cases, particularly in non-smoking patients
Read More
UK MRC and AstraZeneca partner for translational clinical research
The partnership will provide six MRC clinical fellows with industry placement opportunities
Read More
Leading with Purpose
AstraZeneca’s Andrea Mugan shares her unique perspectives on patients, experience, change and challenges
Read More
AZ/Merck’s Lynparza approved by SMC to treat advanced prostate cancer in Scotland
Up to 20% of prostate cancer cases are classified as castration-resistant
Read More
Milner Therapeutics to establish new genomics laboratory for drug discovery
The new state-of-the-art facility is set to be operational in early 2024
Read More
AstraZeneca granted licence for Nanoform’s AI technology
STARMAP will accelerate the selection of AZ’s best molecule candidates
Read More
AstraZeneca reveals new research to improve drug discovery
The study used data from 50,000 people in the UK Biobank
Read More
AstraZeneca and SAS link up on AI and analytics
Collaboration will enable teams across the organisation to increase clinical research innovation
Read More
AstraZeneca’s Soliris approved in Japan for paediatric gMG patients
The drug is the first to be approved in Japan to treat children and adolescents with generalised myasthenia gravis
Read More
Two AstraZeneca therapies accepted in Scotland
Tezspire is a drug for severe asthma and Forxiga is used to treat chronic heart failure
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
